KR101095940B1 - 주사가능한 불용성 글로빈 이식체 - Google Patents

주사가능한 불용성 글로빈 이식체 Download PDF

Info

Publication number
KR101095940B1
KR101095940B1 KR1020057021442A KR20057021442A KR101095940B1 KR 101095940 B1 KR101095940 B1 KR 101095940B1 KR 1020057021442 A KR1020057021442 A KR 1020057021442A KR 20057021442 A KR20057021442 A KR 20057021442A KR 101095940 B1 KR101095940 B1 KR 101095940B1
Authority
KR
South Korea
Prior art keywords
formulation
globin
skin
film
paste
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020057021442A
Other languages
English (en)
Korean (ko)
Other versions
KR20060009325A (ko
Inventor
진-루이스 태요트
Original Assignee
코리오닉스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코리오닉스 filed Critical 코리오닉스
Publication of KR20060009325A publication Critical patent/KR20060009325A/ko
Application granted granted Critical
Publication of KR101095940B1 publication Critical patent/KR101095940B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41Porphyrin- or corrin-ring-containing peptides
    • A61K38/42Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60Materials for use in artificial skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
KR1020057021442A 2003-05-12 2004-05-05 주사가능한 불용성 글로빈 이식체 Expired - Fee Related KR101095940B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0305700A FR2854801B1 (fr) 2003-05-12 2003-05-12 Implant injectable de globine insoluble
FR0305700 2003-05-12
PCT/FR2004/001082 WO2004100934A1 (fr) 2003-05-12 2004-05-05 Implant injectable de globine insoluble

Publications (2)

Publication Number Publication Date
KR20060009325A KR20060009325A (ko) 2006-01-31
KR101095940B1 true KR101095940B1 (ko) 2011-12-19

Family

ID=33306302

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057021442A Expired - Fee Related KR101095940B1 (ko) 2003-05-12 2004-05-05 주사가능한 불용성 글로빈 이식체

Country Status (11)

Country Link
EP (1) EP1622596B1 (enExample)
JP (1) JP4642765B2 (enExample)
KR (1) KR101095940B1 (enExample)
CN (1) CN100566709C (enExample)
AU (1) AU2004237992B2 (enExample)
BR (1) BRPI0411169A (enExample)
CA (1) CA2525049C (enExample)
FR (1) FR2854801B1 (enExample)
MX (1) MXPA05012073A (enExample)
WO (1) WO2004100934A1 (enExample)
ZA (1) ZA200508886B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889449B1 (fr) 2005-08-05 2011-06-10 Khorionyx Preparations implantables
CN101522228A (zh) * 2006-08-02 2009-09-02 克赫里昂恩克斯公司 尤其可用于组织填补和瘢痕形成的可植入制剂
FR2920666B1 (fr) * 2007-09-11 2010-11-26 Khorionyx Preparations implantables contenant de la globine, procede pour leur fabrication et utilisations
US20120183501A1 (en) 2010-11-12 2012-07-19 Jean-Louis Tayot Novel method for treatment of skin wounds and preparations for implementation of same
EP2781224A1 (en) * 2013-03-18 2014-09-24 Khorionyx Implantable preparations comrpsing globin insoluble at physiological pH and serum for regeneration of tissues and treatment of wounds.
CN109453078B (zh) * 2018-11-19 2021-09-21 中国人民解放军陆军军医大学第一附属医院 一种仿生基质水凝胶面膜及其制备方法
CN110841115A (zh) * 2019-11-13 2020-02-28 中国科学院遗传与发育生物学研究所 一种胶原凝胶支架及其在提高自体脂肪细胞移植存活率中的应用
CN113713180A (zh) * 2021-08-31 2021-11-30 尚诚怡美(成都)生物科技有限公司 一种交联人源白蛋白真皮填充剂及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999017786A1 (en) * 1997-10-08 1999-04-15 Theragem, Inc. Mammalian-derived peptides for the treatment of microbial infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB494327A (en) * 1936-01-17 1938-10-24 Du Pont Improvements in or relating to protein derivatives
FR2548671B1 (fr) * 1983-07-07 1986-05-02 Merieux Inst Procede de preparation de globine a partir d'hemoglobine et globine obtenue par ce procede
JP2001503299A (ja) * 1996-11-05 2001-03-13 チャレンジ バイオプロダクツ カンパニー,リミテッド ジェニピンによる生物医学的材料の化学改変
CN1520885A (zh) * 1997-10-23 2004-08-18 ������ҩ��ʽ���� 可室温贮存的免疫球蛋白静脉注射制剂
EP2311407A1 (en) * 1999-05-18 2011-04-20 CryoLife, Inc. Method of making a self-supported, shaped, three-dimensional biomaterial structure
AU2002215387B2 (en) * 2000-10-24 2005-09-29 Cryolife, Inc. In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics
US20020122816A1 (en) * 2000-12-18 2002-09-05 Hsing-Wen Sung Use of 3-hydroxypropinoaldehyde in crosslinking and sterilizing a biomolecule, and a biocompatible implant, substitute or wound dressing containing the crosslinked biomolecule

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999017786A1 (en) * 1997-10-08 1999-04-15 Theragem, Inc. Mammalian-derived peptides for the treatment of microbial infection

Also Published As

Publication number Publication date
FR2854801B1 (fr) 2006-09-01
AU2004237992A1 (en) 2004-11-25
KR20060009325A (ko) 2006-01-31
CA2525049A1 (fr) 2004-11-25
JP4642765B2 (ja) 2011-03-02
MXPA05012073A (es) 2006-06-23
EP1622596B1 (fr) 2015-10-14
ZA200508886B (en) 2008-09-25
JP2006528672A (ja) 2006-12-21
EP1622596A1 (fr) 2006-02-08
CN100566709C (zh) 2009-12-09
CN1787812A (zh) 2006-06-14
AU2004237992B2 (en) 2010-12-23
CA2525049C (fr) 2013-04-02
WO2004100934A1 (fr) 2004-11-25
BRPI0411169A (pt) 2006-07-18
FR2854801A1 (fr) 2004-11-19

Similar Documents

Publication Publication Date Title
US6949625B2 (en) Injectable implant of insoluble globin
US7709017B2 (en) Implantable preparations
KR101922538B1 (ko) 상처 치유 조성물의 제조를 위한 방법, 튜브 및 장치
US10576037B2 (en) Compositions comprising placental collagen for use in wound healing
JP4214051B2 (ja) エラスチン架橋体およびその製造方法
CN115501253A (zh) 联合干细胞和水凝胶生物材料制备及其在脊髓损伤的应用
US20240131222A1 (en) Transdermal photocuring forming hydrogel with biological activity as well as a preparation method and an application thereof
CN113663137B (zh) 复合生物补片及其制备方法及应用
JP2016514716A (ja) 組織の再生および創傷の治療のための植え込み型製剤、それらの製剤化方法、および該植え込み型製剤を用いる患者の治療方法
KR101095940B1 (ko) 주사가능한 불용성 글로빈 이식체
JP2011510971A (ja) 中性pHで可溶性の終末的に滅菌されたコラーゲンの製造
CN104548201B (zh) 一种角膜组织修复材料及其制备方法
BRPI0714099A2 (pt) preparação estéril implantável, preparação adesiva e uso de uma preparação
WO2024166078A1 (en) A novel dual-curable human amniotic membrane hydrogel for regenerative medicine injectable scaffold for regenerative medicine
JPWO2003094985A1 (ja) 人工細胞外マトリックス及びその製造方法
RU2715715C1 (ru) Стерильный прозрачный концентрированный раствор биосовместимого коллагена, способ его получения и применения
CN110711264B (zh) 复合材料、医用粘合剂及其制备方法和应用
KR20060091350A (ko) 해양생물로부터 추출된 콜라겐을 이용하여 제조된 조직공학용 고분자 지지체 및 그 콜라겐의 추출방법
US20090074736A1 (en) Implantable preparations comprising globin, process for their production, and uses
CN116514956A (zh) 重组人源化iii型胶原蛋白及其应用
CN112353997A (zh) 一种可吸收胶原蛋白海绵制备方法及应用
CN116510065B (zh) 重组人源化iii型胶原蛋白止血海绵及其应用
CN110893250B (zh) 瘢痕/粘连阻挡膜及其制备方法和用途
Ramesh DEVELOPMENT AND OPTIMIZATION OF A BIOCOMPATIBLE HYDROGEL FOR SKIN REGENERATION COMPOSITES.
Meenakshi et al. Versatile Silk Polymers and Nanoparticles for Biomedical Applications

Legal Events

Date Code Title Description
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20141125

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20151125

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20161125

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20171127

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20181214

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20181214